stockrowCastle Biosciences, Inc. (CSTL) vs OPKO Health, Inc. (OPK)
- Castle Biosciences, Inc. CSTL 32.65 −4.53%
- OPKO Health, Inc. OPK 1.74 −0.57%
Castle Biosciences, Inc. and OPKO Health, Inc. are both Diagnostics & Research companies. OPKO Health, Inc. is the larger, with a market value of $1.3B against $1.0B — 1.3× the size. Castle Biosciences, Inc. grew revenue faster over the last twelve months: 9.78% against −21.9%. Castle Biosciences, Inc. has the higher net margin (−6.10% vs −29.5%) and the higher return on invested capital (−3.63% vs −6.72%). Across the 18 metrics below, Castle Biosciences, Inc. leads on 15 and OPKO Health, Inc. on 3.
Valuation
Profitability
| Metric | CSTL | OPK | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 77.07% | 46.22% | 48.32% |
| Operating margin | (7.43%) | (25.46%) | (5.68%) |
| Net margin | (6.10%) | (29.51%) | (4.10%) |
| Free cash flow margin | 1.06% | (26.91%) | 0.00% |
| Return on equity | (4.87%) | (12.23%) | 0.00% |
| Return on assets | (4.03%) | (7.64%) | (6.05%) |
| Return on invested capital | (3.63%) | (6.72%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack